$311 Million is the total value of March Altus Capital Management LP's 28 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 64.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | Sell | DEXCOM INC | $28,904,000 | -2.2% | 698,835 | -16.3% | 9.28% | +3.6% |
| ALKS | ALKERMES PLC | $20,407,000 | +8.4% | 462,853 | 0.0% | 6.55% | +14.9% | |
| MON | Sell | MONSANTO CO NEW | $18,446,000 | -20.5% | 162,131 | -18.5% | 5.92% | -15.7% |
| LLY | Buy | LILLY ELI & CO | $15,780,000 | +36.4% | 268,087 | +18.2% | 5.07% | +44.6% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $15,677,000 | – | 166,725 | +100.0% | 5.03% | – |
| ATHN | Buy | ATHENAHEALTH INC | $13,126,000 | +47.4% | 81,916 | +23.7% | 4.21% | +56.2% |
| PODD | New | INSULET CORP | $12,837,000 | – | 270,717 | +100.0% | 4.12% | – |
| AGN | Sell | ALLERGAN INC | $11,991,000 | +2.2% | 96,627 | -8.5% | 3.85% | +8.3% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $11,538,000 | -0.1% | 181,966 | -17.7% | 3.70% | +5.8% |
| ZLTQ | Sell | ZELTIQ AESTHETICS INC | $11,493,000 | -19.7% | 586,065 | -22.5% | 3.69% | -14.8% |
| BIIB | New | BIOGEN IDEC INC | $11,310,000 | – | 36,976 | +100.0% | 3.63% | – |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $11,275,000 | -7.3% | 74,111 | -18.9% | 3.62% | -1.7% |
| ZTS | New | ZOETIS INCcl a | $10,440,000 | – | 360,761 | +100.0% | 3.35% | – |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $10,157,000 | -13.5% | 123,759 | -14.4% | 3.26% | -8.3% |
| HCA | Sell | HCA HOLDINGS INC | $10,144,000 | -42.1% | 193,226 | -47.4% | 3.26% | -38.7% |
| INCY | New | INCYTE CORP | $9,751,000 | – | 182,192 | +100.0% | 3.13% | – |
| CYBX | Sell | CYBERONICS INC | $9,307,000 | -14.9% | 142,636 | -14.5% | 2.99% | -9.8% |
| WST | Sell | WEST PHARMACEUTICAL SVSC INC | $9,198,000 | -44.4% | 208,801 | -38.1% | 2.95% | -41.1% |
| LMNX | New | LUMINEX CORP DEL | $9,090,000 | – | 501,923 | +100.0% | 2.92% | – |
| TNDM | Sell | TANDEM DIABETES CARE INC | $8,135,000 | -26.2% | 368,263 | -14.0% | 2.61% | -21.8% |
| UNIS | Buy | UNILIFE CORP NEW | $7,567,000 | +2.5% | 1,859,185 | +10.8% | 2.43% | +8.6% |
| ENZY | Buy | ENZYMOTEC LTD | $7,222,000 | +31.7% | 327,962 | +61.6% | 2.32% | +39.7% |
| HLS | Sell | HEALTHSOUTH CORP | $6,922,000 | -34.4% | 192,639 | -39.1% | 2.22% | -30.4% |
| ARAY | ACCURAY INC | $6,591,000 | +10.2% | 686,569 | 0.0% | 2.12% | +16.8% | |
| NUVA | New | NUVASIVE INC | $6,287,000 | – | 163,675 | +100.0% | 2.02% | – |
| FURX | New | FURIEX PHARMACEUTICALS INC | $6,087,000 | – | 69,960 | +100.0% | 1.95% | – |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $5,935,000 | -51.3% | 129,042 | -49.5% | 1.90% | -48.4% |
| XON | New | INTREXON CORP | $5,864,000 | – | 223,037 | +100.0% | 1.88% | – |
| GNMK | Exit | GENMARK DIAGNOSTICS INC | $0 | – | -223,818 | -100.0% | -0.90% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -51,545 | -100.0% | -1.74% | – |
| MMC | Exit | MARSH & MCLENNAN COS INC | $0 | – | -120,350 | -100.0% | -1.76% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -152,809 | -100.0% | -1.79% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -72,955 | -100.0% | -3.39% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -243,399 | -100.0% | -3.43% | – |
| HUM | Exit | HUMANA INC | $0 | – | -112,502 | -100.0% | -3.52% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -174,370 | -100.0% | -3.67% | – |
| AON | Exit | AON PLC | $0 | – | -146,694 | -100.0% | -3.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 12 | Q3 2016 | 14.4% |
| LILLY ELI & CO | 12 | Q3 2016 | 20.0% |
| ALEXION PHARMACEUTICALS INC | 11 | Q3 2016 | 15.1% |
| MALLINCKRODT PUB LTD CO | 8 | Q3 2015 | 7.0% |
| UNITED THERAPEUTICS CORP DEL | 7 | Q3 2015 | 11.7% |
| REGENERON PHARMACEUTICALS | 7 | Q3 2016 | 14.6% |
| UNIVERSAL HLTH SVCS INC | 7 | Q2 2015 | 12.1% |
| ZOETIS INC | 7 | Q3 2016 | 5.2% |
| INCYTE CORP | 6 | Q4 2015 | 14.7% |
| EDWARDS LIFESCIENCES CORP | 5 | Q3 2016 | 28.5% |
View March Altus Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-07 |
| 13F-HR | 2016-07-27 |
| 13F-HR | 2016-05-12 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View March Altus Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.